bioAffinity Technologies (BIAFW) Revenue
Market Cap: $26.98M
Avg Volume: -
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is bioAffinity Technologies's Revenue?
bioAffinity Technologies's quarterly revenue as of Q2 2024 is $2.40M.
bioAffinity Technologies's annual revenue for the fiscal year 2023 is $2.53M.
Related metrics for bioAffinity Technologies (quarterly):
- Cost of Revenue: $1.56M
- Gross Profit: $838.87K
- Gross Profit Ratio: 34.99%
- Revenue Per Share: $0.21
- Revenue Growth: -0.36%
Apple's quarterly revenue was $2.40M, with a cost of revenue of $1.56M, which leaves $838.87K gross profit and a gross profit ratio of 34.99%.
Related metrics for bioAffinity Technologies (annual):
- Cost of Revenue: $1.99M
- Gross Profit: $542.02K
- Gross Profit Ratio: 21.40%
- Revenue Per Share: $0.29
- Revenue Growth: 52627.44%
Apple's annual revenue was $2.53M, with a cost of revenue of $1.99M, which leaves $542.02K gross profit and a gross profit ratio of 21.40%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
Note: The historical revenue chart displays quarterly revenue data.
Note: The revenue growth chart displays annual growth percentages.
Note: The revenue per share chart displays revenue per share data.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2023.
| Year | Revenue | Change |
|---|---|---|
| 2023 | $2.53M | 52627.44% |
| 2022 | $4.80K | N/A |
| 2021 | $- | N/A |
| 2020 | $- | N/A |
| 2019 | $- | N/A |